Published in Vaccine Weekly, February 20th, 2002
Pancreatic cancer (PC) is a biologically complex disease that is highly resistant to treatment. For more than 80% of patients with pancreatic cancer, no effective treatment exists, and few patients with advanced stage disease are alive after one year. Therefore, any well-tolerated, efficacious therapy would encounter few obstacles on its way to market penetration.
Experts contacted by Decision Resources consider therapeutic vaccines and epidermal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly